1. Home
  2. KRNT vs ARVN Comparison

KRNT vs ARVN Comparison

Compare KRNT & ARVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kornit Digital Ltd.

KRNT

Kornit Digital Ltd.

HOLD

Current Price

$14.36

Market Cap

666.1M

Sector

Industrials

ML Signal

HOLD

Logo Arvinas Inc.

ARVN

Arvinas Inc.

HOLD

Current Price

$11.95

Market Cap

781.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNT
ARVN
Founded
2002
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
666.1M
781.0M
IPO Year
2015
2018

Fundamental Metrics

Financial Performance
Metric
KRNT
ARVN
Price
$14.36
$11.95
Analyst Decision
Buy
Buy
Analyst Count
4
23
Target Price
$19.75
$17.89
AVG Volume (30 Days)
279.1K
955.1K
Earning Date
02-11-2026
02-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$210,041,000.00
$312,300,000.00
Revenue This Year
$3.86
$11.17
Revenue Next Year
$2.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.17
93.86
52 Week Low
$11.93
$5.90
52 Week High
$32.09
$21.00

Technical Indicators

Market Signals
Indicator
KRNT
ARVN
Relative Strength Index (RSI) 56.43 51.12
Support Level $14.01 $11.86
Resistance Level $14.65 $12.50
Average True Range (ATR) 0.49 0.50
MACD 0.01 -0.12
Stochastic Oscillator 61.83 39.74

Price Performance

Historical Comparison
KRNT
ARVN

About KRNT Kornit Digital Ltd.

Kornit Digital Ltd develops, designs and markets digital printing solutions for the world-wide printed textile industry. The company focuses on its DTG and DTF segments of the printed textile industry. Its solutions include digital printing systems, ink and other consumables, associated software and value-added services that allow for large-scale printing of short runs of complex images and designs directly on finished garments and fabrics. It generates revenue from sales of systems, ink and other consumables and service including software subscriptions The company geographically operates in U.S., EMEA, Asia Pacific and other countries. It derives maximum revenue from U.S.

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

Share on Social Networks: